|
Mar 11
|
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
|
|
Mar 11
|
15 Best NASDAQ Dividend Stocks To Buy
|
|
Mar 10
|
Gilead Sciences, Inc. (NASDAQ:GILD) Pays A US$0.77 Dividend In Just Three Days
|
|
Mar 10
|
3 Dividend Stocks to Buy Hand Over Fist in March
|
|
Mar 7
|
Why Gilead Sciences (GILD) Outpaced the Stock Market Today
|
|
Mar 7
|
Why Is Gilead (GILD) Down 2.4% Since Last Earnings Report?
|
|
Mar 7
|
Gilead (GILD) & MRK's HIV Oral Combo Shows Efficacy in Phase II
|
|
Mar 6
|
Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
|
|
Mar 6
|
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
|
|
Mar 6
|
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock
|
|
Mar 6
|
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
|
|
Mar 6
|
Gilead bets on ‘trispecifics’ in latest cancer drug deal
|
|
Mar 5
|
New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19
|
|
Mar 5
|
Gilead’s Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
|
|
Mar 5
|
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
|
|
Mar 4
|
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
|
|
Jan 30
|
Kite Receives U.S. FDA Approval of Manufacturing Process Change Resulting in Reduced Median Turnaround Time for Yescarta® CAR T-cell Therapy
|
|
Jan 30
|
From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease
|
|
Jan 29
|
Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why
|
|
Jan 29
|
Gilead and Arcus Announce Amended Collaboration and Equity Investment
|